Publication: ICAM-1 interactions in the renal interstitium: A novel activator of fibroblasts during nephritis
Loading...
Date
1999
Authors
Clayton, A. ; Steadman, R.
item.page.secondaryauthor
item.page.director
Publisher
Murcia : F. Hernández
publication.page.editor
publication.page.department
DOI
item.page.type
info:eu-repo/semantics/article
Description
Abstract
Chronic renal diseases often degenerate
towards end-stage failure, requiring replacement renal
therapy. The progressive decline of such diseases is a
highly complex, multi-factorial process, which is poorly
understood. Indeed, not all chronic conditions take on a
progressive course, some may recover to regain normal
function, while others may remain functionally impaired
yet stable. The structural features of progressive decline,
however, show common histological features, despite
the diverse nature of the primary injury. These aberrant
structural alterations are characterised essentially by a
dramatic expansion of the tubulointerstitium, with
accompanying tubular atrophy, resulting from interstitial
fibrosis. These changes are thought to be a uniform
response to prolonged inflammation which may
originate in the glomerulus, the vasculature or the
interstitial space (Strutz et al., 1995).
A histomorphometric analysis of renal diseases,
initially performed by Risdon et al. (1968), and
supported by Bohle et al. (1987) and others (Eknoyan et
al., 1990), revealed that the severity of abnormal
glomerular pathology did not always correlate directly
with impaired renal function. The extent of interstitial
inflammation and the degree of interstitial fibrosis however, were both shown to be more accurate
predictors of renal function (Bohle et al., 1992).
Furthermore there was a high probability of irreversible
functional decline, in the presence of interstitial fibrotic
lesions and tubular atrophy. Interstitial fibrosis is
therefore considered an important histological marker
for end stage renal failure, and is believed to be
functionally more significant than primary changes
within the glomerulus.
In most tissues, resident fibroblasts are believed to
be the cells principally responsible for the synthesis and
breakdown of extracellular matrix (ECM) within '
connective tissues. Indeed in fibrotic diseases of lung
and skin, the resident fibroblast has been identified as the most important cell responsible for the abnormal
deposition of ECM components during the disease
process (Phan et al., 1985). In the kidney, there are
probably several sources of matrix components during
fibrosis including tubular epithelia1 cells, inflammatory
macrophages (Vaage and Linbland, 1990) as well as
interstitial fibroblasts. Although the precise cellular
source of the bulk of this matrix requires clarification,
there is mounting evidence supporting a significant
contribution from resident or infiltrating fibroblasts
(Rodemann and Muller, 1990, 1991a,b; Strutz and
Muller, 1995).
publication.page.subject
Citation
item.page.embargo
Ir a Estadísticas
Sin licencia Creative Commons.